Risk factors for lung function decline in a large cohort of young cystic fibrosis patients.
about
Pediatric Pulmonology year in review 2015: Part 4.Early childhood lung function is a stronger predictor of adolescent lung function in cystic fibrosis than early Pseudomonas aeruginosa infection.The Microbiome in Cystic Fibrosis.Factors Associated with Worse Lung Function in Cystic Fibrosis Patients with Persistent Staphylococcus aureus.Early Lung Function Decline in Cystic Fibrosis: Can Registry Data Explain Divergent Phenotypes?One Center's Guide to Outpatient Management of Pediatric Cystic Fibrosis Acute Pulmonary Exacerbation.The Use of Home Spirometry in Pediatric Cystic Fibrosis Patients: Results of a Feasibility Study.Cystic Fibrosis: Microbiology and Host ResponsePseudomonas aeruginosa and post-tracheotomy bacterial respiratory tract infection readmissions.Consequences of Expiratory Flow Limitation at Rest in Subjects with Cystic Fibrosis.Data that empower: The success and promise of CF patient registries.Incident Stenotrophomonas maltophilia infection and lung function decline in cystic fibrosis.Staphylococcus aureus α toxin potentiates opportunistic bacterial lung infections.Antibiotic perturbation of mixed-strain Pseudomonas aeruginosa infection in patients with cystic fibrosis.Stenotrophomonas maltophilia: A marker of lung disease severity.The Prevalence and Significance of Staphylococcus aureus in Patients with non-Cystic Fibrosis Bronchiectasis.A semiquantitative MRI-Score can predict loss of lung function in patients with cystic fibrosis: Preliminary results.Heparin-binding protein in sputum as a marker of pulmonary inflammation, lung function, and bacterial load in children with cystic fibrosis.
P2860
Q30250335-7CDD37E3-C0FF-4BD2-8463-C61ECA51F466Q33688123-B27E7DCA-C0EF-443C-B592-D0417D70D5B0Q35917770-DE623F8E-C367-43F1-B04C-CAD2B06580BBQ36197194-9505EAEF-59CC-4CAB-9D72-C0738F964F90Q36371926-BEBBC389-111A-441E-A1CC-DEBA27062996Q37094805-280CF602-6B4F-4675-9B17-7D273D3A2867Q37641385-A33958A0-099B-4C2D-8A9D-3B3254ACA03EQ38911644-C365F692-A99A-417F-82CB-36A9E36B352FQ39261292-818EC129-E2AE-464F-AD77-D13A7F5107CEQ39740014-A9204A34-05BB-4B8B-8EDD-5E12BD33A5AAQ40041155-FAAAD913-0962-45E8-A4EC-5361E61879EDQ40090307-9F0A48C7-0F95-46DA-B69A-9264550167FCQ40761003-5F34393B-78D5-458D-A2E7-C8D06DB545D5Q47103711-7C5D18A3-34D1-4618-8733-A4DB31C1EE0EQ47190939-4E9E8DFA-2731-446C-BE12-6143854C28F3Q47643862-7A167205-1DCE-433E-8AD8-B1ED24A655F7Q47847809-2F5C8B22-74EA-4013-AFF2-C5DC2BC96A15Q55297570-0087D4CB-FC41-45F1-AF10-853944F480A2
P2860
Risk factors for lung function decline in a large cohort of young cystic fibrosis patients.
description
2015 nî lūn-bûn
@nan
2015 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Risk factors for lung function ...... oung cystic fibrosis patients.
@ast
Risk factors for lung function ...... oung cystic fibrosis patients.
@en
type
label
Risk factors for lung function ...... oung cystic fibrosis patients.
@ast
Risk factors for lung function ...... oung cystic fibrosis patients.
@en
prefLabel
Risk factors for lung function ...... oung cystic fibrosis patients.
@ast
Risk factors for lung function ...... oung cystic fibrosis patients.
@en
P2093
P2860
P356
P1476
Risk factors for lung function ...... oung cystic fibrosis patients.
@en
P2093
Clement Ren
Don B Sanders
EPIC Study Group
Jonathan Cogen
Julia Emerson
Margaret Rosenfeld
Michael S Schechter
Ronald L Gibson
Wayne Morgan
P2860
P304
P356
10.1002/PPUL.23217
P577
2015-06-09T00:00:00Z